Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac neurosurgical navigation robot in the Chinese market. This collaboration aligns with Brain Navi's 2025 globalization strategy, prioritizing localized partnerships to accelerate market entry and enhance clinical adoption.
China's surgical robotics industry is experiencing rapid growth. According to Frost& Sullivan market research, the surgical robot market size is projected to exceed USD 3 billion by 2026 and reach USD 9.5 billion by 2030. As the demand for neurosurgical precision and automation increases, Brain Navi's NaoTrac, a cutting-edge AI-powered navigation system, will play a crucial role in enhancing patient outcomes in neurosurgery.
Through this partnership, BenQ Medical Technology will leverage its extensive hospital network across China to facilitate NaoTrac's clinical deployment. This collaboration is further supported by China's 14th Five-Year Plan for the Development of the Medical Equipment Industry, which aims to foster domestic innovation and promote intelligent medical solutions.
"This collaboration marks BenQ Medical Technology as a key step in integrating surgical robots and expanding applications in smart operating rooms," said Michael Kuan, the President of BenQ Medical Technology. "With the rapid advancements in AI and robotic technology, intelligent healthcare is the future. Working with Brain Navi, we are committed to driving the adoption of surgical robotics in China, providing patients with precise, safe, and innovative solutions."
Dr. Jerry Chen, CEO of Brain Navi, emphasized the importance of regional partnerships, stating, "NaoTrac has been used in some medical centers across Asia, Latin America, and Europe. Partnering with BenQ Medical Technology gives us a robust gateway into the Chinese market, where localization is key to success. By combining our AI-driven surgical technology with BenQ Medical Technology's strong market presence, we are confident in accelerating the adoption of neurosurgical robotics in China."
As part of its 2025 strategy, Brain Navi continues to expand its global footprint, with current key focus areas in EMEA, the Asia-Pacific region, and Latin America. The company is committed to providing localized support through distributor empowerment, hospital collaborations, and advanced training programs tailored to the needs of neurosurgeons worldwide. By fostering strong alliances with distributors and hospital networks, the company ensures the seamless integration of neurosurgical robotics into regional healthcare systems.
Brain Navi will present NaoTrac at the AANS (American Association of Neurological Surgeons) Annual Meeting, scheduled for April 25–28, 2025, in Boston, MA. This event will offer distributors, hospitals, and neurosurgeons a chance to experience the future of neurosurgical robotics firsthand.
Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac neurosurgical navigation robot in the Chinese market. This collaboration aligns with Brain Navi's 2025 globalization strategy, prioritizing localized partnerships to accelerate market entry and enhance clinical adoption.China's surgical robotics industry is experiencing rapid growth. According to Frost& Sullivan market research, the surgical robot market size is projected to exceed USD 3 billion by 2026 and reach USD 9.5 billion by 2030. As the demand for neurosurgical precision and automation increases, Brain Navi's NaoTrac, a cutting-edge AI-powered navigation system, will play a crucial role in enhancing patient outcomes in neurosurgery.Through this partnership, BenQ Medical Technology will leverage its extensive hospital network across China to facilitate NaoTrac's clinical deployment. This collaboration is further supported by China's 14th Five-Year Plan for the Development of the Medical Equipment Industry, which aims to foster domestic innovation and promote intelligent medical solutions."This collaboration marks BenQ Medical Technology as a key step in integrating surgical robots and expanding applications in smart operating rooms," said Michael Kuan, the President of BenQ Medical Technology. "With the rapid advancements in AI and robotic technology, intelligent healthcare is the future. Working with Brain Navi, we are committed to driving the adoption of surgical robotics in China, providing patients with precise, safe, and innovative solutions."Dr. Jerry Chen, CEO of Brain Navi, emphasized the importance of regional partnerships, stating, "NaoTrac has been used in some medical centers across Asia, Latin America, and Europe. Partnering with BenQ Medical Technology gives us a robust gateway into the Chinese market, where localization is key to success. By combining our AI-driven surgical technology with BenQ Medical Technology's strong market presence, we are confident in accelerating the adoption of neurosurgical robotics in China."As part of its 2025 strategy, Brain Navi continues to expand its global footprint, with current key focus areas in EMEA, the Asia-Pacific region, and Latin America. The company is committed to providing localized support through distributor empowerment, hospital collaborations, and advanced training programs tailored to the needs of neurosurgeons worldwide. By fostering strong alliances with distributors and hospital networks, the company ensures the seamless integration of neurosurgical robotics into regional healthcare systems.Brain Navi will present NaoTrac at the AANS (American Association of Neurological Surgeons) Annual Meeting, scheduled for April 25–28, 2025, in Boston, MA. This event will offer distributors, hospitals, and neurosurgeons a chance to experience the future of neurosurgical robotics firsthand.
Recently, there have been instances of individuals using forged BenQ Medical Technology Corp business cards to impersonate colleagues from the mainland, claiming to be seeking accommodation. In accordance with legal advice, we will be taking preventative measures and would like to remind the public and all our partners: please be vigilant as there are individuals who may be impersonating BenQ Medical Technology Corp to engage in fraudulent activities. If you receive any suspicious communication or contact, or notice a change in the way you are being contacted, please be sure to proactively reach out to BenQ Medical Technology Corp to safeguard your interests.
